A pilot study examining the efficacy of Keppra [levetiracetam] in acute alcohol related seizure control in the emergency department setting.

Trial Profile

A pilot study examining the efficacy of Keppra [levetiracetam] in acute alcohol related seizure control in the emergency department setting.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2018

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Seizures
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jun 2018 Planned primary completion date changed from 1 Jul 2008 to 2 Feb 2008.
    • 05 Jun 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 16 Oct 2009 UCB added as sponsor as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top